Redcare Pharmacy

German Regulatory Updates And Digital Rx Adoption Will Transform Healthcare

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

30 Dec 24

Updated

01 May 25

Views

n/a

AnalystConsensusTarget's Fair Value

n/a

-51.5%

5.3%

-51.5%

5.3%

You can edit this narrative until May 12 6:01 AM. Then, changes will post as Updates.

Author's Valuation

€153.7557.1% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates8

Shared on 01 May 25

Fair value Decreased 18%

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Increased 2.08%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 2.69%

AnalystConsensusTarget has decreased profit margin from 2.5% to 1.7% and increased future PE multiple from 33.8x to 50.6x.

Shared on 12 Mar 25

Fair value Decreased 5.68%

AnalystConsensusTarget has increased profit margin from 2.1% to 2.5% and decreased future PE multiple from 43.7x to 33.8x.

AnalystConsensusTarget Fair Value

€153.75

57.1% undervalued

Future estimation in

Growth p.a.

Decrease

Increase

Current revenue growth rate

15.39%

Food and Staples Retail revenue growth rate

0.18%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

5.25%

Calculation

€102.38m

Earnings '28

34.86x

PE Ratio '28

€3.57b

Market Cap '28

€3.57b

Market Cap '28

20.34m

No. shares '28

€175.42

Share Price '28

€175.42 Share Price '28

Discounted to 2025 @ 5.09% p.a.

€151.16

Fair Value '25